德乌克拉维西提尼:中度至重度斑块性牛皮是可以预防的吗?
1Department of Pharmacology, Kalpana Chawla Government Medical College, Karnal, Haryana, India.
概括
杜克拉维西替尼 (deucravacitinib) 是一种选择性口服TYK2抑制剂,为中度至重度的斑块性牛皮提供了一个新的治疗选择. 本综述审查了它在治疗这种慢性自身免疫性疾病方面的有效性和安全性.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种慢性,炎症性自身免疫性疾病,患病率可变.
- 目前的治疗包括局部疗法,光疗和全身药物,但存在局限性.
- 持续需要创新和有效的牛皮治疗方法.
研究的目的:
- 审查deucravacitinib在牛皮管理中的疗效和安全性.
- 提供deucravacitinib的作用机制的概述.
- 讨论其在治疗免疫介导疾病中的潜在作用.
主要方法:
- 审查关于deucravacitinib的当前知识.
- 分析其作为选择性氨酸激酶2 (TYK2) 抑制剂的机制.
- 审查其批准和在斑块性牛皮治疗中的应用.
主要成果:
- 德乌克拉维西替尼是第一类口服选择性TYK2抑制剂.
- 它通过在TYK2.2内的抑制连接的全稳定作用.
- 美国FDA于2022年9月批准了deucravacitinib用于中度至重度的斑块性牛皮.
结论:
- 德乌克拉维西提尼布代表了一种针对牛皮的新疗法.
- 它的选择性TYK2抑制为免疫介导疾病治疗提供了一个新的机制.
- 预计将有更多关于牛皮管理的长期疗效和安全性的数据.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
114
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
114
Dose-Response Relationship: Potency and Efficacy
4.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156


